Literature DB >> 30506640

Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates.

Emily R Perito1,2, John Bucuvalas3, Jennifer C Lai4.   

Abstract

Functional impairment is associated with mortality in adult liver transplant candidates. This has not been studied in pediatric liver transplant candidates. United Network for Organ Sharing Standard Transplant Analysis and Research files were used to investigate functional status, waitlist mortality, and posttransplant outcomes in children younger than 18 years who were waitlisted in 2006-2016 for primary liver transplant. Functional status was categorized, by using the Lansky Play-Performance Scale (LPPS), as normal/good (80-100), moderately impaired (50-70), or severely impaired (10-40) by center assessment. Among 3250 children not listed as Status 1A, 62% had an LPPS score of 80-100, 25% had a score of 50-70, and 13% had a score of 10-40 at listing. Children with an LPPS score of 10-40 at listing were more likely to die while on the waitlist (standardized hazard ratio 1.85, 95% confidence interval 1.09-3.13, P = .02) in analyses adjusting for being on a ventilator, breathing support, or dialysis and other illness severity measures. For the 2565 children transplanted, an LPPS score of 10-40 at listing drastically increased mortality risk by 1 year posttransplant (hazard ratio 5.77, 95% confidence interval 3.05-10.91, P < .0005). LPPS scores of 10-40 and 50-70 both increased the risk of graft loss by 1 year. Functional status is an independent predictor of waitlist and posttransplant mortality in pediatric liver transplant candidates. Validated tools for the assessment of functional status in these children would improve our ability to predict mortality risk-and to appropriately prioritize them for transplant.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  United Network for Organ Sharing (UNOS); clinical research/practice; health services and outcomes research; liver allograft function/dysfunction; liver transplantation/hepatology; organ allocation; pediatrics; waitlist management

Mesh:

Year:  2018        PMID: 30506640      PMCID: PMC6482090          DOI: 10.1111/ajt.15203

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

1.  Karnofsky performance status before and after liver transplantation predicts graft and patient survival.

Authors:  Paul J Thuluvath; Avesh J Thuluvath; Yulia Savva
Journal:  J Hepatol       Date:  2018-06-06       Impact factor: 25.083

2.  Prevalence and Outcomes of Liver Transplantation in Children With Intellectual Disability.

Authors:  Aaron Wightman; Evelyn Hsu; Qianqian Zhao; Jodi Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-06       Impact factor: 2.839

3.  Functional status of United States children supported with a left ventricular assist device at heart transplantation.

Authors:  Anica Bulic; Katsuhide Maeda; Yulin Zhang; Sharon Chen; Doff B McElhinney; John C Dykes; Amanda M Hollander; Seth A Hollander; Jenna Murray; Olaf Reinhartz; Mary Alice Gowan; David N Rosenthal; Christopher S Almond
Journal:  J Heart Lung Transplant       Date:  2017-03-02       Impact factor: 10.247

4.  A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.

Authors:  Puneeta Tandon; K Rajender Reddy; Jacqueline G O'Leary; Guadalupe Garcia-Tsao; Juan G Abraldes; Florence Wong; Scott W Biggins; Benedict Maliakkal; Michael B Fallon; Ram M Subramanian; Paul Thuluvath; Patrick S Kamath; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Hepatology       Date:  2016-11-29       Impact factor: 17.425

5.  Sarcopenia in Children With End-Stage Liver Disease.

Authors:  Eberhard Lurz; Hiten Patel; Richard G Frimpong; Amanda Ricciuto; Mohit Kehar; Paul W Wales; Alexander J Towbin; Govind B Chavhan; Binita M Kamath; Vicky L Ng
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-02       Impact factor: 2.839

6.  Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study.

Authors:  Fernando Carceller; Francisco J Bautista; Irene Jiménez; Raquel Hladun-Álvaro; Cécile Giraud; Luca Bergamaschi; Madhumita Dandapani; Isabelle Aerts; François Doz; Didier Frappaz; Michela Casanova; Bruce Morland; Darren R Hargrave; Lynley V Marshall; Gilles Vassal; Andrew D J Pearson; Birgit Geoerger; Lucas Moreno
Journal:  Eur J Cancer       Date:  2016-09-21       Impact factor: 9.162

7.  The measurement of performance in childhood cancer patients.

Authors:  S B Lansky; M A List; L L Lansky; C Ritter-Sterr; D R Miller
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

8.  Poor Performance Status Is Associated With Increased Mortality in Patients With Cirrhosis.

Authors:  Eric S Orman; Marwan Ghabril; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-01       Impact factor: 11.382

9.  Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.

Authors:  H J Braun; E R Perito; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2016-06-27       Impact factor: 8.086

10.  Frailty in Children with Liver Disease: A Prospective Multicenter Study.

Authors:  Eberhard Lurz; Claudia Quammie; Michael Englesbe; Estella M Alonso; Henry C Lin; Evelyn K Hsu; Katryn N Furuya; Nitika A Gupta; Veena L Venkat; James F Daniel; Mike A Leonis; Tamir Miloh; Grzegorz W Telega; Jason Yap; Jerome Menendez; Linda S Book; Ryan W Himes; Shikha S Sundaram; Rulan Parekh; Chris Sonnenday; John Bucuvalas; Vicky L Ng; Binita M Kamath
Journal:  J Pediatr       Date:  2018-03       Impact factor: 4.406

View more
  1 in total

1.  Evaluating the Associations Between the Liver Frailty Index and Karnofsky Performance Status With Waitlist Mortality.

Authors:  Chelsea Q Xu; Frederick Yao; Yara Mohamad; Randi Wong; Dorothea Kent; Srilakshmi Seetharaman; Yanin Srisengfa; Jennifer C Lai
Journal:  Transplant Direct       Date:  2021-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.